 If you are found to be eligible to take part in this study, you will be assigned to 1 of 2 study groups, depending on if you are already taking ibrutinib or not. If you are NOT already taking ibrutinib, you will be assigned to Group 1. If you are already taking ibrutinib, you will be assigned to Group 2. 